Integrated immunohistochemical and molecular analysis improves diagnosis of high-grade carcinoma in the urinary bladder of patients with prior radiation therapy for prostate cancer
Emily Chan, Karuna Garg, Bradley A. Stohr
Topics & Concepts
MedicineProstateImmunohistochemistryPathologyProstate cancerCarcinomaTMPRSS2PCA3Urinary bladderMSH2CancerBladder cancerOncologyInternal medicineColorectal cancerDiseaseDNA mismatch repairInfectious disease (medical specialty)Coronavirus disease 2019 (COVID-19)Bladder and Urothelial Cancer TreatmentsProstate Cancer Diagnosis and TreatmentUrologic and reproductive health conditions